サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：デジタル薬局の世界市場：薬剤タイプ別、製品タイプ別、プラットフォーム別、ビジネスモデル別－地域別展望、競合戦略、セグメント予測（～2030年）
市場調査レポート
商品コード
1110905

デジタル薬局の世界市場：薬剤タイプ別、製品タイプ別、プラットフォーム別、ビジネスモデル別－地域別展望、競合戦略、セグメント予測（～2030年）

Global Digital Pharmacy Market- By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 238 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
デジタル薬局の世界市場：薬剤タイプ別、製品タイプ別、プラットフォーム別、ビジネスモデル別－地域別展望、競合戦略、セグメント予測（～2030年）
出版日: 2022年08月05日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 238 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のデジタル薬局の市場規模は、2030年まで16.8%で成長し、3,342億5,000万米ドルに達すると予想されています。

医薬品をオンラインで購入したいという消費者の欲求の高まり、市場の統合とパートナーシップ、高齢者人口の増加は、デジタル薬局市場の成長に寄与しています。しかし、薬局の増加、治療サポートを薬剤師に依存する患者の増加が、市場の成長を抑制しています。

当レポートでは、世界のデジタル薬局市場について調査分析し、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 市場セグメント分析

第2章 調査手法

  • 調査データソース
    • 二次データ
    • 一次データ
    • SPERの内部データベース
    • KOLの洞察
  • 市場規模の推定
    • トップダウンとボトムアップのアプローチ
  • データの三角測量

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 世界のデジタル薬局市場へのCOVID-19の影響

第5章 市場変数と展望

  • SWOT分析
    • 強み
    • 弱点
    • 機会
    • 脅威
  • PESTEL分析
    • 政治的情勢
    • 経済的情勢
    • 社会的情勢
    • 技術的情勢
    • 環境的情勢
    • 法的情勢
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入者の脅威
    • 競争企業間の敵対関係
  • ヒートマップ分析

第6章 世界デジタルファーマシー市場（100万米ドル）（2019年～2030年）：薬剤タイプ別

  • 店頭販売商品
    • 一般用医薬品の使いやすさと利便性が市場の成長を促進
  • 処方薬
    • 高齢者人口の増加とそれに続く慢性疾患の増加による処方薬の需要の高まり

第7章 世界のデジタル薬局市場（100万米ドル）（2019年～2030年）：製品別

  • 薬と治療
    • 糖尿病ケア
    • 心臓ケア
    • 腫瘍
  • ビタミンとサプリメント
    • COVID-19のパンデミックをきっかけに免疫関連サプリメントの需要の高まりとそれによる市場成長の促進
  • パーソナルケア製品
    • 個人の健康と衛生への関心の高まりによる市場成長の促進
  • その他の製品

第8章 世界のデジタル薬局市場（100万米ドル）（2019年～2030年）：プラットフォーム別

  • アプリケーション（AAPS）
    • 非接触型配送などの利点によるAAPSの需要の高まり
  • ウェブサイト
    • 市場成長の促進するためにWebサイトが提供するプロモーション、割引、オファー

第9章 世界のデジタル薬局市場（100万米ドル）（2019年～2030年）：ビジネスモデル別

  • キャプティブ
    • キャプティブモデルの柔軟性、アクセスしやすさ、手頃な価格－市場の成長を促進する主な要因
  • アグリゲーター
    • 市場の成長を促進するためのアグリゲーターモデルに関連する高品質のサービス
  • フランチャイズ
    • 市場の成長を促進する薬局フランチャイズの数の増加

第10章 世界のデジタル薬局市場（100万米ドル）（2019年～2030年）：地理的カバレッジ別

  • 都市部
    • 都市部での急速なインターネット普及による市場における本セグメントの成長の促進
  • 農村部
    • 農村地域におけるデジタル薬局の需要を促進するための政府のイニシアチブ

第11章 世界のデジタル薬局市場（100万米ドル）（2019年～2030年）：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • 中東とアフリカ
    • サウジアラビア王国
    • アラブ首長国連邦
    • その他中東

第12章 企業プロファイル

  • Amazon.com Inc.
  • Apex Pharmacy
  • Apollo Pharmacy
  • Cigna
  • Costco Wholesale Corporation
  • CVS Health
  • DocMorris
  • Giant Eagle Inc.
  • GoodRx
  • HealthWarehouse Inc.
  • Hims & Hers Health Inc.
  • Lloyds Pharmacy
  • Netmeds.com
  • NorthWestPharmacy.com
  • Optum Inc.
  • PharmEasy
  • Pharmex Direct Inc.
  • Rexall Pharmacy Group ULC
  • Rite Aid Corp.
  • Ro Pharmacy
  • Rx Outreach
  • Shop-apotheke.com
  • Tata 1mg
  • TELUS
  • The Independent Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Inc.
目次
Product Code: PHAR2207

According to SPER Market Research, the Digital Pharmacy Market is estimated to reach USD 334.25 billion by 2030 with a CAGR of 16.8%.

The rising consumer desire for purchasing pharmaceuticals online during and after the COVID-19 pandemic, market consolidation and partnerships, and the rising elderly population all contribute to the sector's growth. During the projected period, an increasing number of violent pharmacies and patients who depend on pharmacists for therapeutic support are anticipated to hinder the growth of this market.

Impact of COVID-19 on the Global Digital Pharmacy Market

Other significant reasons boosting the market growth include the expanding number of internet users, more access to online services, and the increased deployment of e-prescriptions in healthcare services in the aftermath of the COVID-19 epidemic. In March 2020, CVS Health began implementing new strategies to balance the demand for medications used throughout the treatment of both COVID-19 and other chronic conditions. In November 2020, Amazon will start an online pharmacy service in the United States for both generic and prescription pharmaceuticals. Before COVID-19, 70% of families were chronic-first consumers of digital pharmacy because they saw superior value in these affordable and convenient services. Nevertheless, as digital pharmacy proved the need of the hour during the lockdown period, an identical amount of chronic-first and acute-first families were onboarded. Furthermore, the rising demand for over-the-counter (OTC) items such as masks, sanitizers, thermometers, and steamers, among others, is supporting the expansion of the digital pharmacy market. As a result, the rapid use of OTC products will benefit the digital pharmacy sector.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Amazon.com Inc., Apex Pharmacy, Apollo Pharmacy, Cigna, Costco Wholesale Corporation, CVS Health, DocMorris, Giant Eagle Inc., GoodRx, HealthWarehouse Inc., Hims & Hers Health Inc., Lloyds Pharmacy, Netmeds.com, NorthWestPharmacy.com, Optum Inc., PharmEasy, Pharmex Direct Inc., Rexall Pharmacy Group ULC, Rite Aid Corp., Ro Pharmacy, Rx Outreach, Shop-apotheke.com, Tata 1mg, TELUS, The Independent Pharmacy, The Kroger Co., Walgreen Co., Walmart Inc.

Global Digital Pharmacy Market, By Drug Type:

Based on the Drug Type, Global Digital Pharmacy Market is segmented as; Over-The-Counter Products (Ease of use and convenience associated with Over-The-Counter products to drive market growth), Prescription Medicines (Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication).

Global Digital Pharmacy Market, By Product:

Based on the Product, Global Digital Pharmacy Market is segmented as; Medicines and Treatments {Diabetes Care (Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments), Heart Care (Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments), Oncology (Increasing prevalence of cancer is a major factor driving the growth of this market segment, Other medicines & treatments)}, Vitamins and Supplements (Growing demand for immunity-associated supplements in the wake of the COVID-19 pandemic to drive market growth), Personal Care Products (Growing focus on personal health & hygiene to drive market growth), Other Products.

Global Digital Pharmacy Market, By Platform:

Based on the Platform, Global Digital Pharmacy Market is segmented as; Applications (AAPS) (Advantages such as contactless delivery will drive the demand for AAPS), Websites (Promotions, discounts, and offers provided by websites to drive market growth).

Global Digital Pharmacy Market, By Business Model:

Based on the Business Model, Global Digital Pharmacy Market is segmented as; Captive (Flexibility, accessibility, and affordability of captive models-key factors driving market growth), Aggregator (Quality services associated with aggregator models to drive market growth), Franchise (Growing number of pharmacy franchises to drive market growth).

Global Digital Pharmacy Market, By Geographic Coverage:

Based on the Geographic Coverage, Global Digital Pharmacy Market is segmented as; Urban Areas (Rapid internet penetration in urban areas to drive market growth in this segment), Rural Areas (Government initiatives to fuel the demand for digital pharmacies in rural areas).

Global Digital Pharmacy Market, By Region:

North America owns the prime share of this market; the major factors of the market's growth in the region are the increasing incidence of chronic illnesses, the growing amount of medicine prescriptions brought on by the region's rapidly aging population, and the expansion of key market participants in the area.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Digital Pharmacy Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Digital Pharmacy Market, By Drug Type, 2019-2030 (USD Million)

  • 6.1. Over-The-Counter Products
    • 6.1.1. Ease of use and convenience associated with Over-The-Counter products to drive market growth
  • 6.2. Prescription Medicines
    • 6.2.1. Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication

7. Global Digital Pharmacy Market, By Product, 2019-2030 (USD Million)

  • 7.1. Medicines and Treatments
    • 7.1.1. Diabetes Care
      • 7.1.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
    • 7.1.2. Heart Care
      • 7.1.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
    • 7.1.3. Oncology
      • 7.1.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
      • 7.1.3.2 Other medicines & treatments
  • 7.2. Vitamins and Supplements
    • 7.2.1 Growing demand for immunity-associated supplements in the wake of the Covid-19 pandemic to drive market growth
  • 7.3. Personal Care Products
    • 7.3.1 Growing focus on personal health & hygiene to drive market growth
  • 7.4. Other Products

8. Global Digital Pharmacy Market, By Platform, 2019-2030 (USD Million)

  • 8.1. Applications (AAPS)
    • 8.1.1 Advantages such as contactless delivery will drive the demand for AAPS
  • 8.2. Websites
    • 8.2.1 Promotions, discounts, and offers provided by websites to drive market growth

9. Global Digital Pharmacy Market, By Business Model, 2019-2030 (USD Million)

  • 9.1. Captive
    • 9.1.1 Flexibility, accessibility, and affordability of captive models-key factors driving market growth
  • 9.2. Aggregator
    • 9.2.1 Quality services associated with aggregator models to drive market growth
  • 9.3. Franchise
    • 9.3.1 Growing number of pharmacy franchises to drive market growth

10. Global Digital Pharmacy Market, By Geographic Coverage, 2019-2030 (USD Million)

  • 10.1 Urban Areas
    • 10.1.1 Rapid internet penetration in urban areas to drive market growth in this segment
  • 10.2 Rural Areas
    • 10.2.1 Government initiatives to fuel the demand for digital pharmacies in rural areas

11. Global Digital Pharmacy Market, By Region, 2019-2030 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Amazon.com Inc.
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 Apex Pharmacy
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 Apollo Pharmacy
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 Cigna
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 Costco Wholesale Corporation
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 CVS Health
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 DocMorris
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Giant Eagle Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 GoodRx
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 HealthWarehouse Inc.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Hims & Hers Health Inc.
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Lloyds Pharmacy
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 Netmeds.com
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 NorthWestPharmacy.com
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Optum Inc.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 PharmEasy
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Pharmex Direct Inc.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Rexall Pharmacy Group ULC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 Rite Aid Corp.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Ro Pharmacy
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21 Rx Outreach
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22 Shop-apotheke.com
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23 Tata 1mg
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24 TELUS
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25 The Independent Pharmacy
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments
  • 12.26 The Kroger Co.
    • 12.26.1. Company details
    • 12.26.2. Financial outlook
    • 12.26.3. Product summary
    • 12.26.4. Recent developments
  • 12.27 Walgreen Co.
    • 12.27.1. Company details
    • 12.27.2. Financial outlook
    • 12.27.3. Product summary
    • 12.27.4. Recent developments
  • 12.28 Walmart Inc.
    • 12.28.1. Company details
    • 12.28.2. Financial outlook
    • 12.28.3. Product summary
    • 12.28.4. Recent developments